These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3161430)

  • 1. Resistance to metocurine-induced neuromuscular blockade in patients receiving phenytoin.
    Ornstein E; Matteo RS; Young WL; Diaz J
    Anesthesiology; 1985 Sep; 63(3):294-8. PubMed ID: 3161430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of metocurine in humans with and without renal failure.
    Brotherton WP; Matteo RS
    Anesthesiology; 1981 Sep; 55(3):273-6. PubMed ID: 7023284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium.
    Ornstein E; Matteo RS; Schwartz AE; Silverberg PA; Young WL; Diaz J
    Anesthesiology; 1987 Aug; 67(2):191-6. PubMed ID: 2886081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise produces sensitivity to metocurine.
    Gronert GA; White DA; Shafer SL; Matteo RS
    Anesthesiology; 1989 Jun; 70(6):973-7. PubMed ID: 2729640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metocurine requirements and plasma concentrations in burned paediatric patients.
    Martyn JA; Goudsouzian NG; Matteo RS; Liu LM; Szyfelbein SK; Kaplan RF
    Br J Anaesth; 1983 Apr; 55(4):263-8. PubMed ID: 6220728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy.
    Soriano SG; Sullivan LJ; Venkatakrishnan K; Greenblatt DJ; Martyn JA
    Br J Anaesth; 2001 Feb; 86(2):223-9. PubMed ID: 11573664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes.
    Kim CS; Arnold FJ; Itani MS; Martyn JA
    Anesthesiology; 1992 Sep; 77(3):500-6. PubMed ID: 1519788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated recovery from doxacurium-induced neuromuscular blockade in patients receiving chronic anticonvulsant therapy.
    Ornstein E; Matteo RS; Weinstein JA; Halevy JD; Young WL; Abou-Donia MM
    J Clin Anesth; 1991; 3(2):108-11. PubMed ID: 1828161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased sensitivity to metocurine in patients with upper motoneuron disease.
    Shayevitz JR; Matteo RS
    Anesth Analg; 1985 Aug; 64(8):767-72. PubMed ID: 3160262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of d-tubocurarine and metocurine in the elderly.
    Matteo RS; Backus WW; McDaniel DD; Brotherton WP; Abraham R; Diaz J
    Anesth Analg; 1985 Jan; 64(1):23-9. PubMed ID: 3966648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and neuromuscular effects of Org NC 45, pancuronium, metocurine, and d-tubocurarine in dogs.
    Booij LH; Edwards RP; Sohn YJ; Miller RD
    Anesth Analg; 1980 Jan; 59(1):26-30. PubMed ID: 7188662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unprecedented resistance to neuromuscular blocking effects of metocurine with persistence after complete recovery in a burned patient.
    Martyn JA; Matteo RS; Szyfelbein SK; Kaplan RF
    Anesth Analg; 1982 Jul; 61(7):614-7. PubMed ID: 6212001
    [No Abstract]   [Full Text] [Related]  

  • 13. Distribution, elimination, and action of d-tubocurarine in neonates, infants, children, and adults.
    Matteo RS; Lieberman IG; Salanitre E; McDaniel DD; Diaz J
    Anesth Analg; 1984 Sep; 63(9):799-804. PubMed ID: 6465573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing pharmacodynamics of metocurine identify the onset and offset of canine gastrocnemius disuse atrophy.
    Fung DL; White DA; Gronert GA; Disbrow E
    Anesthesiology; 1995 Jul; 83(1):134-40. PubMed ID: 7604992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of chronic phenytoin administration on the pharmacokinetics and pharmacodynamics of vecuronium.
    Wright PM; McCarthy G; Szenohradszky J; Sharma ML; Caldwell JE
    Anesthesiology; 2004 Mar; 100(3):626-33. PubMed ID: 15108978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics and pharmacokinetics of metocurine in humans: comparison to d-tubocurarine.
    Matteo RS; Brotherton WP; Nishitateno K; Khambatta HJ; Dias J
    Anesthesiology; 1982 Sep; 57(3):183-90. PubMed ID: 6287887
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH; deBros FM
    Anesth Analg; 1981 Jan; 60(1):12-7. PubMed ID: 7192943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH
    Anesth Analg; 1980 Aug; 59(8):604-9. PubMed ID: 7190795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metocurine pharmacokinetics and pharmacodynamics in goats.
    Antognini JF; Wood R; Gronert GA
    J Vet Pharmacol Ther; 1995 Dec; 18(6):464-7. PubMed ID: 8789701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep sedation and mechanical ventilation without paralysis for 3 weeks in normal beagles: exaggerated resistance to metocurine in gastrocnemius muscle.
    Gronert GA; Fung DL; Haskins SC; Steffey EP
    Anesthesiology; 1999 Jun; 90(6):1741-5. PubMed ID: 10360874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.